These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15047620)

  • 41. Platelet activation in type 2 diabetes mellitus.
    Ferroni P; Basili S; Falco A; Davì G
    J Thromb Haemost; 2004 Aug; 2(8):1282-91. PubMed ID: 15304032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Ganda OP; Arkin CF
    Diabetes Care; 1992 Oct; 15(10):1245-50. PubMed ID: 1425083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmolein.
    Sánchez-Muniz FJ; Oubiña P; Ródenas S; Benedi J; Cuesta C
    Eur J Nutr; 2003 Dec; 42(6):299-306. PubMed ID: 14673602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thromboxane production in diabetes mellitus.
    Altomonte L; Zoli A; Mangia A; Ghirlanda G; Manna R; Bertoli A; Greco AV
    Ric Clin Lab; 1986; 16(4):539-42. PubMed ID: 3576051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
    Alessandrini P; McRae J; Feman S; FitzGerald GA
    N Engl J Med; 1988 Jul; 319(4):208-12. PubMed ID: 3292913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.
    Szénási P; Tóth L; Romics L; Kammerer L
    Acta Diabetol Lat; 1988; 25(1):7-12. PubMed ID: 3407379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants.
    Martín-Gallán P; Carrascosa A; Gussinye M; Domínguez C
    Free Radic Res; 2005 Sep; 39(9):933-42. PubMed ID: 16087474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus.
    Annadurai T; Vasanthakumar A; Geraldine P; Thomas PA
    Diabetes Res Clin Pract; 2014 Jul; 105(1):58-69. PubMed ID: 24842247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet hyperreactivity in hyperlipidaemia with specific reference to platelet lipids and fatty acid composition.
    Chetty N; Naran NH
    Clin Chim Acta; 1992 Dec; 213(1-3):1-13. PubMed ID: 1477981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum lipoprotein(a) in patients with diabetes mellitus.
    Heller FR; Jamart J; Honore P; Derue G; Novik V; Galanti L; Parfonry A; Hondekijn JC; Buysschaert M
    Diabetes Care; 1993 May; 16(5):819-23. PubMed ID: 8495624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus.
    Peerapatdit T; Likidlilid A; Patchanans N; Somkasetrin A
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S141-6. PubMed ID: 17718255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM; Agil A; Mykkanen L; Stern MP; Jialal I
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Correlation between glycemia control and lipid metabolism parameters in children with diabetes mellitus].
    Klinghammer A; Thomser J
    Kinderarztl Prax; 1993 Jun; 61(4-5):151-3. PubMed ID: 8361144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients.
    Jensen T; Truong Q; Frandsen M; Dinesen B; Stender S
    Diabetes Care; 2002 Nov; 25(11):1914-8. PubMed ID: 12401732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term untreated streptozotocin-diabetes leads to increased expression and elevated activity of prostaglandin H2 synthase in blood platelets.
    Siewiera K; Kassassir H; Talar M; Wieteska L; Watala C
    Platelets; 2016; 27(3):203-11. PubMed ID: 26325148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
    Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
    Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes.
    Astley S; Langrish-Smith A; Southon S; Sampson M
    Diabetes Care; 1999 Oct; 22(10):1626-31. PubMed ID: 10526726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma antioxidants and type 2 diabetes mellitus.
    Palanduz S; Ademoğlu E; Gökkuşu C; Tamer S
    Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):309-18. PubMed ID: 12889514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus.
    Coppola L; Verrazzo G; La Marca C; Ziccardi P; Grassia A; Tirelli A; Giugliano D
    Diabet Med; 1997 Nov; 14(11):959-63. PubMed ID: 9400920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.